Cargando…
Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
BACKGROUND: Nanoparticles possess several advantages as a carrier system for intracellular delivery of therapeutic agents. Rapamycin is an immunosuppressive agent which also exhibits marked antiproliferative properties. We investigated whether rapamycin-loaded nanoparticles(NPs) can reduce neointima...
Autores principales: | Zou, Junjie, Zhang, Xiwei, Yang, Hongyu, Zhu, Yi, Ma, Hao, Wang, Shui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115851/ https://www.ncbi.nlm.nih.gov/pubmed/21569412 http://dx.doi.org/10.1186/1749-8090-6-69 |
Ejemplares similares
-
Retraction: Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts
por: Zou, Junjie, et al.
Publicado: (2012) -
Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model
por: Liu, Kai, et al.
Publicado: (2010) -
Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022) -
Patient-Specific, Multi-Scale Modeling of Neointimal Hyperplasia in Vein Grafts
por: Donadoni, Francesca, et al.
Publicado: (2017) -
Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia
por: Bai, Hualong, et al.
Publicado: (2017)